scholarly journals Phase II clinical trial of liposomal-encapsulated doxorubicin citrate and docetaxel, associated with trastuzumab, as neoadjuvant treatment in stages II and IIIA HER2-overexpressing breast cancer patients. GEICAM 2003-03 study

2011 ◽  
Vol 22 (1) ◽  
pp. 74-79 ◽  
Author(s):  
A. Antón ◽  
A. Ruiz ◽  
A. Plazaola ◽  
L. Calvo ◽  
M.A. Seguí ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Clinical Trial ◽  
Cancer Patients ◽  
Phase Ii ◽  
Neoadjuvant Treatment ◽  
Phase Ii Clinical Trial ◽  
Breast Cancer Patients

A Phase II Clinical Trial of Flutamide in the Treatment of Advanced Breast Cancer

1988 ◽  
Vol 74 (1) ◽  
pp. 53-56 ◽  
Author(s):  
Tiping Zhao ◽  
Guifen He
Keyword(s):  
Breast Cancer ◽  
Clinical Trial ◽  
Advanced Breast Cancer ◽  
Cancer Patients ◽  
Phase Ii ◽  
Transient Response ◽  
Postmenopausal Breast Cancer ◽  
Phase Ii Clinical Trial ◽  
Advanced Breast ◽  
Breast Cancer Patients

An antiandrogenic agent flutamide was used in the treatment of one male and 14 female postmenopausal breast cancer patients. Only a mild and transient response was seen in 2 female patients. Therefore, flutamide cannot be used solely in the treatment of female postmenopausal breast cancer.

Sign in / Sign up

Export Citation Format

Share Document